Comparison of prescribing and adherence patterns of anti-osteoporotic medications post-admission for fragility type fracture in an urban teaching hospital and a rural teaching hospital in Ireland between 2005 and 2008.
AffiliationThe North Western Rheumatology Unit, Our Lady's Hospital, Manorhamilton, Co Leitrim, Ireland, email@example.com.
MetadataShow full item record
CitationComparison of prescribing and adherence patterns of anti-osteoporotic medications post-admission for fragility type fracture in an urban teaching hospital and a rural teaching hospital in Ireland between 2005 and 2008. 2013: Ir J Med Sci
JournalIrish journal of medical science
AbstractINTRODUCTION: Poor adherence reduces the potential benefits of osteoporosis therapy, lowering gains in bone mineral density resulting in increased risk of fractures. AIM: To compare prescribing and adherence patterns of anti-osteoporotic medications in patients admitted to an urban teaching hospital in Ireland with a fragility type fracture to patients admitted to a rural hospital in the North Western region. METHODOLOGY: We identified all patients >55 years admitted to Sligo General Hospital between 2005 and 2008 with a fragility fracture (N = 744) using the hospital in-patient enquiry system (HIPE). The medical card number of those patients eligible for the primary care reimbursement services scheme (PCRS) facilitated the linkage of the HSE-PCRS scheme database to the HIPE database which enabled a study to identify persistence rates of patients prescribed osteoporosis therapy after discharge. The results were compared to the findings of a similar study carried out in St. James's Hospital, Dublin. RESULTS: The 12 months post-fracture prescribing increased from 11.0 % (95 % CI 9.6, 12.4) in 2005 to 47 % (95 % CI 43.6, 50.3) in 2008 in the urban setting and from 25 % (95 % CI 21.5, 28.9) to 39 % (95 % CI 34.5, 42.7) in the rural setting. Adherence levels to osteoporosis medications at 12 months post-initiation of therapy was <50 % in both study groups. Patients on less frequent dosing regimes were better adherers. CONCLUSION: The proportion of patients being discharged on anti-osteoporosis medications post-fragility fracture increased between 2005 and 2008 in both patient groups. Sub-optimal adherence levels to osteoporosis medications continue to be a major concern.
- Primary-care prescribing of anti-osteoporotic-type medications following hospitalisation for fractures.
- Authors: McGowan BM, Bennett K, Marry J, Walsh JB, Casey MC
- Issue date: 2011 Mar
- Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
- Authors: Balasubramanian A, Tosi LL, Lane JM, Dirschl DR, Ho PR, O'Malley CD
- Issue date: 2014 Apr 2
- Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.
- Authors: Gonnelli S, Caffarelli C, Iolascon G, Bertoldo F, Letizia Mauro G, Patti A, Nuti R
- Issue date: 2017 Oct
- Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries.
- Authors: Yun H, Curtis JR, Guo L, Kilgore M, Muntner P, Saag K, Matthews R, Morrisey M, Wright NC, Becker DJ, Delzell E
- Issue date: 2014 Apr 1
- Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
- Authors: Klop C, Gibson-Smith D, Elders PJ, Welsing PM, Leufkens HG, Harvey NC, Bijlsma JW, van Staa TP, de Vries F
- Issue date: 2015 Jul